{"id":"NCT03345914","sponsor":"Regeneron Pharmaceuticals","briefTitle":"Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)","officialTitle":"A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Administered Concomitantly With Topical Corticosteroids in Patients, ≥6 Years to <12 Years of Age, With Severe Atopic Dermatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-17","primaryCompletion":"2019-06-20","completion":"2019-09-10","firstPosted":"2017-11-17","resultsPosted":"2020-08-13","lastUpdate":"2020-08-13"},"enrollment":367,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dermatitis, Atopic"],"interventions":[{"type":"DRUG","name":"Dupilumab","otherNames":["DUPIXENT®","REGN668","SAR231893"]},{"type":"DRUG","name":"Matching Placebo","otherNames":[]},{"type":"OTHER","name":"Background Treatment: Topical Corticosteroids","otherNames":[]},{"type":"OTHER","name":"Background Treatment: Moisturizers","otherNames":[]}],"arms":[{"label":"Group 1","type":"EXPERIMENTAL"},{"label":"Group 2","type":"EXPERIMENTAL"},{"label":"Group 3","type":"EXPERIMENTAL"}],"summary":"The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to \\<12 years of age with severe atopic dermatitis (AD).\n\nThe secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 years to \\<12 years of age with severe AD.","primaryOutcome":{"measure":"Percentage of Participants With Investigator's Global Assessment (IGA) 0 or 1 at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo + TCS","deltaMin":11.4,"sd":null},{"arm":"Dupilumab 300 mg Q4W + TCS","deltaMin":32.8,"sd":null},{"arm":"Dupilumab 100 mg or 200 mg Q2W + TCS","deltaMin":29.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"= 0.0004"},{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":61,"countries":["United States","Canada","Czechia","Germany","Poland","United Kingdom"]},"refs":{"pmids":["39588375","37750994","37300760","36269504","34462864","34427891","34270797","34046851"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":120},"commonTop":["Upper respiratory tract infection","Dermatitis atopic","Nasopharyngitis","Headache","Vomiting"]}}